Study of simulect-based, steroid-free immunosuppressive regimen in HCV+ de novo liver transplant patients: preliminary results

By Filipponi F.   Salizzoni M.   Grazi G.   Pisati R.   Ferrara R.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3211-3212

Elsevier

Access to resources Recommend Favorite

Sarcoidosis News: Immunologic Frontiers for New Immunosuppressive Strategies

By Agostini C.   Costabel U.   Semenzato G.  

Clinical Immunology, Vol. 88, Iss. 2, 1998-08 ,pp. : 199-204

Academic Press

Access to resources Recommend Favorite

On the horizon: clinical trials of new immunosuppressive strategies for autoimmune diseases

By Daikh D.I.   Wofsy D.  

Transplantation Proceedings, Vol. 30, Iss. 8, 1998-12 ,pp. : 4027-4028

Elsevier

Access to resources Recommend Favorite

The limitations of calcineurin and mTOR inhibitors: new directions for immunosuppressive strategies

By Kahan B.D.  

Transplantation Proceedings, Vol. 34, Iss. 1, 2002-02 ,pp. : 130-133

Elsevier

Access to resources Recommend Favorite

Pharmacoeconomic evaluation of simulect prophylaxis in renal transplant recipients

By Walters S.J.   Whitfield M.   Akehurst R.L.   Chilcott J.B.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3187-3191

Elsevier

Access to resources Recommend Favorite